Company Search:
Advanced Search
Sponsored Links
KPC Pharmaceuticals Inc Company Snapshot
KPC Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares KPC Pharmaceuticals Inc with three other companies in this sector in China: Guizhou Xinbang Pharmaceutical Company Limited (2017 sales of 6.00 billion Chinese Renmimbi [US$887.05 million] of which 63% was Pharmaceutical industry), FUREN Group Pharmaceutical Co Ltd (5.80 billion Chinese Renmimbi [US$857.11 million] of which 85% was Pharmaceutical Industry), and Zhejiang Medicine Co., Ltd. (5.69 billion Chinese Renmimbi [US$841.25 million] of which 43% was Life Nourishment).

Sales Analysis. KPC Pharmaceuticals Inc reported sales of 5.85 billion Chinese Renmimbi (US$864.85 million) for the year ending December of 2017. This represents an increase of 14.7% versus 2016, when the company's sales were 5.10 billion Chinese Renmimbi. Sales at KPC Pharmaceuticals Inc have increased during each of the previous five years (and since 2012, sales have increased a total of 94%). Sales of Daily Necessities saw an increase that was more than double the company's growth rate: sales were up 351.2% in 2017, from 956,636.43 Chinese Renmimbi to 4.32 million Chinese Renmimbi. KPC Pharmaceuticals Inc also saw significant increases in sales in Oral Agents (up 23.4% to 1.83 billion Chinese Renmimbi) and Injection (up 30.0% to 1.35 billion Chinese Renmimbi) and Medical Services (up 343.3% to 2.88 million Chinese Renmimbi) and Other (up 110.9% to 93.08 million Chinese Renmimbi) . Not all segments of KPC Pharmaceuticals Inc experienced an increase in sales in 2017: sales of Other Operating fell 46.3% to 61.83 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
KPC Pharmaceuticals Inc
  Stock Performance Chart for KPC Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 6.61
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 1.5%  
4 Weeks -14.0%   52 Weeks -17.9%  
KPC Pharmaceuticals Inc Key Data:
  Ticker: 600422 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 5,852,287,433
(Year Ending Jan 2018).
Employees: 4,469
  Currency: Chinese Renmimbi Market Cap: 5,196,766,777
  Fiscal Yr Ends: December Shares Outstanding: 786,197,697
  Share Type: A Gu Closely Held Shares: 333,315,582
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.